Wei Hou
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Pharmacology top 10%
Papers in
-
- Cancer-related gene regulation 3
- Surgery 13
- Esophageal Cancer Research and Treatment 5
- Co-authors
- Siyi Hu (5 shared papers)Chunyu Wang (2 shared papers)Yan Wang (2 shared papers)Nan Song (3 shared papers)Ying‐Wei Yang (3 shared papers)Guangping Meng (2 shared papers)Xinghuo Wang (2 shared papers)Jun Tang (2 shared papers)
- Journals
- BioMed Research International (3 papers)Scientific Reports (2 papers)Future Medicinal Chemistry (2 papers)Advanced Materials (2 papers)Injury (1 paper)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Wei Hou
47 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 118
- Cancer Research 156
- Pharmacology 52
- Biomaterials 75
- Oncology 155
- Complementary and alternative medicine 45
Countries citing papers authored by Wei Hou
This map shows the geographic impact of Wei Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Hou more than expected).
Fields of papers citing papers by Wei Hou
This network shows the impact of papers produced by Wei Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Hou. The network helps show where Wei Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 161 | |
| 2 | 2019 | 116 | |
| 3 | 2018 | 80 | |
| 4 | 2020 | 67 | |
| 5 | 2012 | 52 | |
| 6 | 2022 | 47 | |
| 7 | Her-2/neu expression and gene amplification in gastrinomas: correlations with tumor biology, growth, and aggressiveness. | 2002 | 44 |
| 8 | 2022 | 39 | |
| 9 | 2018 | 37 | |
| 10 | 2020 | 35 | |
| 11 | 2023 | 34 | |
| 12 | 2021 | 33 | |
| 13 | 2018 | 33 | |
| 14 | [Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs]. | 2010 | 33 |
| 15 | 2007 | 32 | |
| 16 | 2018 | 31 | |
| 17 | 2020 | 29 | |
| 18 | 2018 | 27 | |
| 19 | 2020 | 22 | |
| 20 | 2020 | 21 |
About Wei Hou
Wei Hou is a scholar working on Molecular Biology, Surgery, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Oncology, having authored 51 papers that have together received 1.1k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (5 papers), Gastrointestinal Tumor Research and Treatment (4 papers), Cancer Mechanisms and Therapy (4 papers), Metastasis and carcinoma case studies (4 papers), Cancer Cells and Metastasis (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers), Cancer-related gene regulation (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (156 citations), Pharmacology (52 citations), Biomaterials (75 citations), Oncology (155 citations) and Complementary and alternative medicine (45 citations). Wei Hou has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Siyi Hu, Chunyu Wang, Yan Wang, Nan Song, Ying‐Wei Yang, Guangping Meng, Xinghuo Wang, Jun Tang, Hanbin Ma and Lihua Dong. Their work appears in journals such as BioMed Research International, Scientific Reports, Future Medicinal Chemistry, Advanced Materials and Injury.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.